Monitoring Specific T-Cell Responses to Melanoma Vaccines: ELISPOT, Tetramers, and Beyond
Year: 2000
Type: article
Abstract: The molecular identification of antigens expressed preferentially in tumor cells has enabled the development of antigen-specific vaccines against human cancer. The majority of human tumor antigens characterized to date have been isolated from melanoma cells based on class I major histocompatibility
Author: Thomas F. Gajewski
Institution: University of Chicago
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: diamond
OpenAlex ID: W2157990159